Pharmgenomics Partners - ME York, Kennebunkport 04046

Pharmgenomics Partners entered the industry of Commercial Biotechnical Research in 2013 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 541711, which describes it as a Commercial Biotechnical Research. For further clarification, the SIC classifies this business under the code 8731 and described it as a Commercial Biotechnical Research. The business provides service to the B2B market.

To acquire more information, please contact Peter Ciriello by calling (207) 229-8810 during business hours. You can also write to the business’ Single Location at 126 Ocean Avenue, Kennebunkport, Maine ME 04046. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .

Company: Pharmgenomics Partners
Representative: Peter Ciriello
Place of Business: 126 Ocean Avenue, Kennebunkport, ME 04046
Contact Number: (207) 229-8810
Type of Service: Commercial Biotechnical Research
SIC Number: 8731
NAICS Number: 541711
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2013
Income/Year: $100.000 to $499.999
Laborers: 1 to 4
Share This Company:

Pharmgenomics Partners is a company operating from York, Maine providing professional Commercial Biotechnical Research and relevant B2B variables. It was founded in 2013 and registered with the SIC code 8731 as Commercial Biotechnical Research, and with the NAICS code 541711 as Commercial Biotechnical Research.

With a current employee count of 1 to 4, Pharmgenomics Partners has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Peter Ciriello at (207) 229-8810 for related queries, or to locate its Single Location using the coordinates 43.34898,-70.472211.

The Single Location can also be found at the street address 126 Ocean Avenue in Kennebunkport, Maine 04046 and can be engaged online through the company website at , the company Twitter , and Facebook page .